Targeting mechanisms of Siglec15-mediated immune evasion in hematologic malignancies |
Emory University / Christopher Porter, MD |
Innovation Grants |
2019 |
Georgia |
Investigation of Pediatric Rhabdomyosarcoma Recurrence through Single-Cell Sequencing |
St. Jude Children's Research Hospital / Anand Patel, MD/PhD |
Young Investigator Grants |
2019 |
Tennessee |
Using Splice Switching Oligonucleotides (SSOs) to target MDM2 for rhabdomyosarcoma therapy |
Research Institute at Nationwide Children's Hospital / Dawn Chandler, PhD |
Innovation Grants |
2019 |
Ohio |
The Role of Tumor Heterogeneity in Relapse of Pediatric Acute Myeloid Leukemia |
Children's Hospital & Research Center at Oakland / Cheryl Peretz, MD |
Young Investigator Grants |
2019 |
California |
MLL Oncogene-Dependent Enhancer Reprogramming Promotes Leukemogenesis |
Stanford University / Feng Pan, PhD |
Young Investigator Grants |
2019 |
California |
Kidney Disease after CD19-Targeted Chimeric Antigen Receptor T Cell Therapy for Pediatric Acute Lymphoblastic Leukemia |
Children's Hospital of Philadelphia / Regina Myers, MD |
Young Investigator Grants |
2019 |
Pennsylvania |
Cooperating Signaling Networks Regulate Cell Survival of Pediatric Ph-like ALL |
University of Pennsylvania / Christian Hurtz, PhD |
Young Investigator Grants |
2018 |
Pennsylvania |
Alternative Splicing Driven by MYCN Activates RAS-MAPK in Neuroblastoma |
University of California San Francisco / William Weiss, MD/PhD |
Innovation Grants |
2018 |
California |
Accessing Combinatorial Effect of PARP Inhibitor with DNA Damaging Agent in Rhabdomyosarcoma at Single Cell Resolution |
Massachusetts General Hospital / Chuan Yan, PhD |
Young Investigator Grants |
2018 |
Massachusetts |
Targeting the ALT Pathway to Induce Synthetic Lethality and Treat Poor Outcome Pediatric Tumors |
University of California, Davis / Wolf-Dietrich Heyer, PhD |
Innovation Grants |
2018 |
California |